NCT00134706 A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00134654 Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer Status COMPLETED Phase PHASE2
NCT00130689 Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer Status COMPLETED Phase PHASE2
NCT00130117 Study of Leptin for the Treatment of Hypothalamic Amenorrhea Status COMPLETED Phase PHASE2
NCT00130026 Caffeine in the Prevention of Post-operative Nausea and Vomiting Status COMPLETED Phase NA
NCT00127491 Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury Status COMPLETED Phase NA
NCT00126191 Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma Status TERMINATED Phase PHASE2
NCT00123851 Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00123825 Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer Status COMPLETED Phase PHASE2
NCT00122369 Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy Status COMPLETED Phase PHASE2
NCT00121134 Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer Status COMPLETED Phase NA
NCT00117156 Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00116506 Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00116220 Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer Status COMPLETED Phase PHASE3
NCT00115843 Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring Status WITHDRAWN Phase NA
NCT00110149 Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00081731 Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions Status COMPLETED Phase PHASE3